BrainCells Inc. Report issue

For profit Phase 1 Phase 2
Founded: San Diego CA United States (2003)
Status: Defunct (2014)

Organization Overview

First Clinical Trial
2008
NCT00621270
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (5)

bci-024 (1 trial)

bci-049 (1 trial)

bci-540 (1 trial)

buspirone (buspar) (1 trial)

melatonin (1 trial)

Drugs in Phase 1 Trials (4)

bci-1038 (1 trial)

bci-1206 (1 trial)

bci-1283 (1 trial)

bci-838 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anxiety Disorders (Phase 2)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 2)

Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 9